1 - 25 of 32 results for author:"Zatloukal K." in Literature citations
Results Customize
› Repeat search in UniProtKB (8)
| Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin. Min L., Ji Y., Bakiri L., Qiu Z., Cen J., Chen X., Chen L., Scheuch H., Zheng H., Qin L. et al. Nat. Cell Biol. 14:1203-1211(2012) · Mapped (23) |
| Genetic background effects of keratin 8 and 18 in a DDC-induced hepatotoxicity and Mallory-Denk body formation mouse model. Haybaeck J., Stumptner C., Thueringer A., Kolbe T., Magin T.M., Hesse M., Fickert P., Tsybrovskyy O., Muller H., Trauner M. et al. Lab. Invest. 92:857-867(2012) · Mapped (3) |
| Hepatobiliary transporter expression and post-operative jaundice in patients undergoing partial hepatectomy. Bernhardt G.A., Zollner G., Cerwenka H., Kornprat P., Fickert P., Bacher H., Werkgartner G., Muller G., Zatloukal K., Mischinger H.J. et al. Liver Int. 32:119-127(2012) · Mapped (15) |
| The KRAB-containing zinc-finger transcriptional regulator ZBRK1 activates SCA2 gene transcription through direct interaction with its gene product, ataxin-2. Hallen L., Klein H., Stoschek C., Wehrmeyer S., Nonhoff U., Ralser M., Wilde J., Rohr C., Schweiger M.R., Zatloukal K. et al. Hum. Mol. Genet. 20:104-114(2011) · Mapped (4) |
| Farnesoid X receptor critically determines the fibrotic response in mice but is expressed to a low extent in human hepatic stellate cells and periductal myofibroblasts. Fickert P., Fuchsbichler A., Moustafa T., Wagner M., Zollner G., Halilbasic E., Stoger U., Arrese M., Pizarro M., Solis N. et al. Am. J. Pathol. 175:2392-2405(2009) · Mapped (11) |
| A lymphotoxin-driven pathway to hepatocellular carcinoma. Haybaeck J., Zeller N., Wolf M.J., Weber A., Wagner U., Kurrer M.O., Bremer J., Iezzi G., Graf R., Clavien P.A. et al. Cancer Cell 16:295-308(2009) · Mapped (53) |
| Clusterin expression in cholestasis, hepatocellular carcinoma and liver fibrosis. Aigelsreiter A., Janig E., Sostaric J., Pichler M., Unterthor D., Halasz J., Lackner C., Zatloukal K., Denk H. Histopathology 54:561-570(2009) · Mapped (5) |
| Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation. Hui L., Zatloukal K., Scheuch H., Stepniak E., Wagner E.F. J. Clin. Invest. 118:3943-3953(2008) · Mapped (30) |
| Hepatocyte survival in acute hepatitis is due to c-Jun/AP-1-dependent expression of inducible nitric oxide synthase. Hasselblatt P., Rath M., Komnenovic V., Zatloukal K., Wagner E.F. Proc. Natl. Acad. Sci. U.S.A. 104:17105-17110(2007) · Mapped (19) |
| Clusterin associates with altered elastic fibers in human photoaged skin and prevents elastin from ultraviolet-induced aggregation in vitro. Janig E., Haslbeck M., Aigelsreiter A., Braun N., Unterthor D., Wolf P., Khaskhely N.M., Buchner J., Denk H., Zatloukal K. Am. J. Pathol. 171:1474-1482(2007) · Mapped (5) |
| Reduced expression of vacuole membrane protein 1 affects the invasion capacity of tumor cells. Sauermann M., Sahin O., Sultmann H., Hahne F., Blaszkiewicz S., Majety M., Zatloukal K., Fuzesi L., Poustka A., Wiemann S. et al. |
| Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis. Zollner G., Wagner M., Fickert P., Silbert D., Gumhold J., Zatloukal K., Denk H., Trauner M. Liver Int. 27:920-929(2007) · Mapped (8) |
| In vitro production of Mallory bodies and intracellular hyaline bodies: the central role of sequestosome 1/p62. Stumptner C., Fuchsbichler A., Zatloukal K., Denk H. Hepatology 46:851-860(2007) · Mapped (3) |
| Hepatobiliary transporter expression in intercellular adhesion molecule 1 knockout and Fas receptor-deficient mice after common bile duct ligation is independent of the degree of inflammation and oxidative stress. Wagner M., Zollner G., Fickert P., Gumhold J., Silbert D., Fuchsbichler A., Gujral J.S., Zatloukal K., Denk H., Jaeschke H. et al. Drug Metab. Dispos. 35:1694-1699(2007) · Mapped (13) |
| The differentiation antigen NY-BR-1 is a potential target for antibody-based therapies in breast cancer. Seil I., Frei C., Sultmann H., Knauer S.K., Engels K., Jager E., Zatloukal K., Pfreundschuh M., Knuth A., Tseng-Chen Y. et al. Int. J. Cancer 120:2635-2642(2007) · Mapped (1) |
| 24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Fickert P., Wagner M., Marschall H.U., Fuchsbichler A., Zollner G., Tsybrovskyy O., Zatloukal K., Liu J., Waalkes M.P., Cover C. et al. Gastroenterology 130:465-481(2006) · Mapped (2) |
| Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth. Corvinus F.M., Orth C., Moriggl R., Tsareva S.A., Wagner S., Pfitzner E.B., Baus D., Kaufmann R., Huber L.A., Zatloukal K. et al. Neoplasia 7:545-555(2005) · Mapped (7) |
| Role of nuclear receptors and hepatocyte-enriched transcription factors for Ntcp repression in biliary obstruction in mouse liver. Zollner G., Wagner M., Fickert P., Geier A., Fuchsbichler A., Silbert D., Gumhold J., Zatloukal K., Kaser A., Tilg H. et al. Am. J. Physiol. Gastrointest. Liver Physiol. 289:G798-805(2005) · Mapped (6) |
| Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Fickert P., Fuchsbichler A., Wagner M., Zollner G., Kaser A., Tilg H., Krause R., Lammert F., Langner C., Zatloukal K. et al. Gastroenterology 127:261-274(2004) · Mapped (2) |
| Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestine. Zollner G., Fickert P., Fuchsbichler A., Silbert D., Wagner M., Arbeiter S., Gonzalez F.J., Marschall H.U., Zatloukal K., Denk H. et al. J. Hepatol. 39:480-488(2003) · Mapped (4) |
| Mallory body -- a disease-associated type of sequestosome. Stumptner C., Fuchsbichler A., Heid H., Zatloukal K., Denk H. |
| Cytokeratins as targets for bile acid-induced toxicity. Fickert P., Trauner M., Fuchsbichler A., Stumptner C., Zatloukal K., Denk H. Am. J. Pathol. 160:491-499(2002) · Mapped (2) |
| p62 Is a common component of cytoplasmic inclusions in protein aggregation diseases. Zatloukal K., Stumptner C., Fuchsbichler A., Heid H., Schnoelzer M., Kenner L., Kleinert R., Prinz M., Aguzzi A., Denk H. Am. J. Pathol. 160:255-263(2002) · UniProtKB (1) |
| Induction of short heterodimer partner 1 precedes downregulation of Ntcp in bile duct-ligated mice. Zollner G., Fickert P., Silbert D., Fuchsbichler A., Stumptner C., Zatloukal K., Denk H., Trauner M. Am. J. Physiol. Gastrointest. Liver Physiol. 282:G184-91(2002) · Mapped (1) |
| Embryonic lethality and fetal liver apoptosis in mice lacking the c-raf-1 gene. Mikula M., Schreiber M., Husak Z., Kucerova L., Ruth J., Wieser R., Zatloukal K., Beug H., Wagner E.F., Baccarini M. EMBO J. 20:1952-1962(2001) · Mapped (11) |